Purpose: We aimed to perform a systematic review of the literature concerned with timing of surgery after anterior cruciate ligament injury.

Methods: A systematic electronic search in Medline through PubMed, Embase, and the Cochrane Library was carried out in October 2011. All English-language randomized controlled clinical trials, prospective comparative cohort studies, and prognostic and diagnostic studies published from January 1995 to August 2011 were eligible for inclusion. All articles addressing timing of surgery were eligible for inclusion regardless of injury-to-surgery interval, graft type, surgical technique, or rehabilitation. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist guided the reporting and data abstraction. Methodologic quality of all included articles was carefully assessed.

Results: We included 22 articles (3,583 patients) in the systematic review. Study design, research methodology, surgical technique, and outcome measurements differed greatly among included articles. The injury-to-surgery interval, classified as early and delayed, ranged from within 2 days to 7 months and 3 weeks to 24 years, respectively. Eight articles promoted early reconstruction, whereas the majority of articles found no difference in outcome between early and delayed surgery. Two articles were inconclusive.

Conclusions: There were few or no differences in subjective and objective outcomes related to timing of anterior cruciate ligament reconstruction.

Level Of Evidence: Level II, systematic review of Level I and II studies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.arthro.2013.07.270DOI Listing

Publication Analysis

Top Keywords

timing surgery
12
anterior cruciate
12
cruciate ligament
12
systematic review
12
included articles
12
surgery anterior
8
eligible inclusion
8
injury-to-surgery interval
8
surgical technique
8
early delayed
8

Similar Publications

Robotic bronchoscopy: Evolution of advanced diagnostic technologies for pulmonary lesions.

Best Pract Res Clin Anaesthesiol

March 2024

1400 Holcombe Blvd, FC 13.2000, Houston, TX, 77030, USA. Electronic address:

Lung cancer is among one of the most commonly diagnosed malignancies and is the leading cause of cancer-related mortality in both men and women globally, with an estimated 1.8 million deaths annually. Moreover, it is also the leading cause of cancer related deaths in the United States (U.

View Article and Find Full Text PDF

Objective: To evaluate factors impacting access to and timing of surgery in patients with submucous cleft palate (SMCP) and velopharyngeal dysfunction (VPD).

Study Design: Retrospective cohort study.

Setting: Single academic medical center.

View Article and Find Full Text PDF

Avascular necrosis (AVN) of the hip, a rare cause of pelvic pain in the third trimester of pregnancy, often presents with nonspecific symptoms that resemble common musculoskeletal conditions. This ambiguity, coupled with concerns about the safety of magnetic resonance imaging (MRI) during pregnancy, can hinder timely diagnosis. We report a unique case of a 32-year-old primigravida diagnosed with a hip fracture and bilateral AVN of the femoral head in the immediate postpartum period, a complication seemingly not previously documented in pregnant patients.

View Article and Find Full Text PDF

Heterotopic pregnancy is defined as the concurrent presence of both an intrauterine pregnancy and an extrauterine (typically ectopic) pregnancy. This report presents the case of a 36-year-old female patient who presented to the emergency department with lower abdominal pain. A comprehensive evaluation, including transabdominal and transvaginal ultrasound imaging, revealed a heterotopic pregnancy at an estimated gestational age of six weeks and two days.

View Article and Find Full Text PDF

Curative immunotherapy-based strategies for non-metastatic non-small cell lung cancer.

Explor Target Antitumor Ther

December 2024

Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL 32224, US.

The emergence of immunotherapy has ushered in a new era in the management of non-small cell lung cancer (NSCLC). Various immune check point inhibitors have demonstrated significant benefit in the management of locally advanced NSCLC that are treated with either surgery or concurrent chemoradiation. We provide a comprehensive and up-to-date review of data from key studies, discuss the challenging clinical issue regarding the timing and duration of immunotherapy in patients undergoing surgery, and highlight the unmet needs and future directions of immunotherapy in NSCLC.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!